Please login to the form below

Not currently logged in
Email:
Password:

ASH meeting

This page shows the latest ASH meeting news and features for those working in and with pharma, biotech and healthcare.

Dutch biotech Argenx claims $1.8bn licensing deal with J&J

Dutch biotech Argenx claims $1.8bn licensing deal with J&J

Argenx is due to report data at the American Society of Haematology (ASH) meeting in San Diego this week  in 12 AML patients, with the abstract showing a 92% overall response

Latest news

More from news
Approximately 4 fully matching, plus 22 partially matching documents found.

Latest Intelligence

  • Deal Watch November 2016 Deal Watch November 2016

    This is despite some positive news for Juno released at the recent ASH meeting that another of its CAR T cell therapeutics, JCAR017, showed a 60% complete response in patients with ... As Juno wrestles with bad publicity and a depressed share price,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Highlights in haematologic malignancy from ASH 2018

    The ASH congress is the most comprehensive haematology event of the year, over 5000 abstracts covering new developments in malignant and non-malignant haematology were presented. ... Earlier this month, Porterhouse Medical attended the 60. th. American

  • Random42 Attending ASH Annual Meeting in San Diego

    Random42 will be attending the ASH annual meeting in San Diego from December 1st – 4th. ... Now in its 60th year the American Society of Hematology (ASH) annual meeting and exposition is the premier event in malignant and non-malignant hematology.

  • Random42 Scientific Communication

    Random42 Attending ASH Annual Meeting in San Diego. ... Random42 will be attending the ASH annual meeting in San Diego from December 1st – 4th.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics